Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News BioSig Technologies Inc BSGM

Healthcare Medical Devices
BioSig Technologies, Inc. is a medical technology company focused on deciphering the body’s electrical signals, starting with heart rhythms. The Company’s product, the PURE EP Platform, a non-invasive class II device, provides real-time signal visualization allowing physicians to perform highly targeted cardiac ablation procedures. Integrating with existing systems in the EP lab, PURE EP is... see more

Recent & Breaking News (NDAQ:BSGM)

BioSig Awarded Additional US Patent Claims for its PURE EP(TM) System

GlobeNewswire January 14, 2020

BioSig Technologies Announces New Collaboration on Development of Artificial Intelligence Solutions in Healthcare

GlobeNewswire December 3, 2019

BioSig Technologies Signs Three New Licensing Agreements with Mayo Clinic

GlobeNewswire November 26, 2019

BioSig Commences Clinical Trial Enrollment for PURE EP System

GlobeNewswire November 21, 2019

BioSig Technologies Welcomes the Creation of New Bioelectronic Medicine Alliance

GlobeNewswire November 18, 2019

BioSig Technologies Issues November 2019 Shareholder Letter

GlobeNewswire November 14, 2019

BioSig Technologies Invests in Union College's Internship Program

GlobeNewswire November 7, 2019

Sasha Gentling, CFA Joins BioSig as Director of Business Development

GlobeNewswire November 6, 2019

BioSig Appoints Andrew Ballou as Vice President of Investor Relations

GlobeNewswire October 29, 2019

BioSig Opens a Technology Development Office in Rochester, MN

GlobeNewswire October 15, 2019

BioSig to Participate at The 14th Annual International Symposium on Ventricular Arrhythmias: Pathophysiology & Therapy

GlobeNewswire October 10, 2019

BioSig to Present Clinical Observations at Venice Arrhythmias 2019

GlobeNewswire September 30, 2019

Global Marketing and Strategy Leader Martha Pease Joins BioSig Board of Directors

GlobeNewswire September 26, 2019

BioSig Technologies Signs a New Licensing Agreement with Mayo Clinic

GlobeNewswire September 12, 2019

BioSig's Subsidiary NeuroClear Technologies, Inc. Raises $3.7 million

GlobeNewswire September 5, 2019

BioSig Allowed Additional Foundational US Patent for its PURE EP(tm) System

GlobeNewswire August 1, 2019

Julie Stephenson Joins BioSig as Senior Director of Clinical Affairs

GlobeNewswire July 24, 2019

Olivier Chaudoir Joins BioSig as Director of Marketing

GlobeNewswire July 18, 2019

BioSig Technologies, Inc. to Receive 15 Units of PURE EP(TM) System from Manufacturer for Commercial Installation - Corrected Version

GlobeNewswire July 15, 2019

BioSig Technologies, Inc. to Receive 15 Units of PURE EP(TM) System from Manufacturer for Commercial Installation

GlobeNewswire July 15, 2019